| P50 | author | Eric J. Topol | Q5387640 |
| | Peter B. Berger | Q7172602 |
| | Steve Steinhubl | Q57450607 |
| P2093 | author name string | Steven P Dunn | |
| | Richard J Charnigo | |
| | Deborah Bauer | |
| P2860 | cites work | Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel | Q46199177 |
| | Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. | Q50357085 |
| | Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction | Q57243377 |
| | Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation | Q57300220 |
| | Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms | Q80495498 |
| | ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and | Q82364672 |
| | Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies | Q85036168 |
| | Use of proton pump inhibitors and mortality among institutionalized older people | Q85103495 |
| | Meta-analysis in clinical trials | Q27860779 |
| | Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events | Q28166894 |
| | Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial | Q28194232 |
| | Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial | Q28199508 |
| | A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee | Q29620666 |
| | Clopidogrel: review of bioanalytical methods, pharmacokinetics/pharmacodynamics, and update on recent trends in drug-drug interaction studies | Q33378137 |
| | Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study | Q34009506 |
| | Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction | Q34168972 |
| | A population-based study of the drug interaction between proton pump inhibitors and clopidogrel | Q34603772 |
| | Clopidogrel with or without omeprazole in coronary artery disease | Q34660303 |
| | Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome | Q34956075 |
| | Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study | Q35222839 |
| | Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials | Q37590925 |
| | The prevalence of co-administration of clopidogrel and proton pump inhibitors. | Q37894155 |
| | Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial | Q38477257 |
| | Increased Use of Acid‐Suppressing Drugs Before the Occurrence of Ischemic Events: A Potential Source of Confounding in Recent Observational Studies | Q42875458 |
| | Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study | Q42882409 |
| | Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study | Q42961046 |
| P433 | issue | 1 | |
| P921 | main subject | clopidogrel | Q410237 |
| P304 | page(s) | e004564 | |
| P577 | publication date | 2013-01-15 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials | |
| P478 | volume | 2 | |